Nan Jing Ha Bai Yi Yao Ke Ji You Xian Gong Si

Nanjing Habo Pharmaceutical Technology Co., Ltd. was established in 2010. The company specializes in the research and development, production, sales and various outsourcing services of biopharmaceuticals, fine chemical intermediates and biochemical reagents; it is committed to the development, customization and production of raw materials, pharmaceutical intermediates and other products. As the company's sales and R&D center, Habo officially moved into the Jiangsu Life Science and Technology Innovation Park in January 2013. Through nearly five years of development, the company has cultivated a group of excellent R&D teams and large-scale production talents. In four years, the team has completed the process development of more than 700 compounds and the marketization and industrialization of more than 50 compounds; it has overcome the difficulties of large-scale production and market expansion of pharmaceutical organosilicon, amplification, preservation and detection of Grignard reagents, amplification of boric acid series, and focused on the development of pharmaceutical organic fluorine series, and applied for a number of invention patents. Habo Pharmaceuticals continues to deepen and improve its product structure, and is committed to providing global pharmaceutical companies and biotechnology companies with high-value-added products and services required for new drug development, helping customers reduce the cost of new drug development and shorten the time to market for new drugs, and has accumulated highly competitive technical resources and extensive customer resources. Since its establishment, the company has established a solid cooperative relationship with well-known domestic pharmaceutical manufacturers in a short period of time with a flexible cooperation model, professional and fast service, and good reputation, laying a solid foundation for future long-term development. In 2012, the 1,200-square-meter R&D and analysis center newly invested by Habo Pharmaceuticals has been put into use; In addition, in order to meet the development of business, Habo established a foreign trade development department in January 2012, successfully applied for import and export rights in June 2012, and self-operated and agent import and export business. In 2014, the company's large-scale production plant began to be built. The company adheres to the advanced cultural concept of "quality first, integrity-based, customer service, and technological innovation"; It always insists on continuous innovation of product structure and creates efficient and environmentally friendly market-oriented large-scale scientific and technological products. Habo's strong scientific research strength, excellent team management, combined with marketing strategies for the international market, have formed Habo's core competitiveness.